GlobeNewswire 6/27/2019 Ziopharm Oncology Initiates Phase 2 Trial Evaluating Combination Therapy of Controlled IL-12 with Li...
GlobeNewswire 6/26/2019 Ziopharm Oncology Completes Enrollment of Controlled IL-12 plus Opdivo® (nivolumab) Phase 1 Combinat...
GlobeNewswire 6/17/2019 Ziopharm Oncology Appoints Heidi Hagen to Board of Directors
TeleTrader 6/11/2019 Macron says would back Merkel for EC presidency
GlobeNewswire 6/11/2019 Ziopharm Oncology Announces FDA Clearance of IND for Sleeping Beauty TCR-T Cell Therapy Trial at NCI
GlobeNewswire 6/2/2019 Ziopharm Oncology Provides Positive Clinical Data for Controlled IL-12 for the Treatment of Recurren...
GlobeNewswire 5/28/2019 Ziopharm Oncology Announces Exclusive License with National Cancer Institute to Identify and Use T-C...
GlobeNewswire 5/23/2019 Ziopharm Oncology Presentation at the Jefferies 2019 Global Healthcare Conference to be Webcast
GlobeNewswire 5/8/2019 Ziopharm Oncology Reports First Quarter 2019 Financial Results and Reaffirms Clinical Timelines
GlobeNewswire 5/1/2019 Ziopharm Oncology to Host Conference Call to Discuss First Quarter 2019 Financial Results on May 8, ...
GlobeNewswire 4/1/2019 Ziopharm Oncology Announces FDA Fast Track Designation for Ad-RTS-hIL-12 plus Veledimex for the Trea...
GlobeNewswire 3/5/2019 Ziopharm Oncology Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate...
GlobeNewswire 2/25/2019 Ziopharm Oncology to Announce Fourth Quarter and Full Year 2018 Financial Results and Host Conferenc...
GlobeNewswire 2/22/2019 Cloud Deployments of Computer Aided Dispatch Systems Surge Despite Security Concerns, finds Fact.MR ...
GlobeNewswire 2/21/2019 Ziopharm Oncology CEO to Present at the CAR-TCR Summit Europe
GlobeNewswire 2/11/2019 Ziopharm Oncology Completes Enrollment of Controlled IL-12 Monotherapy Expansion Substudy in Phase 1...
GlobeNewswire 2/6/2019 Rising Tide Systems lights are perfect complement to TrolMaster Systems for growing, combining innov...
GlobeNewswire 1/7/2019 Ziopharm Oncology Posts Letter to Stockholders
GlobeNewswire 12/27/2018 Ziopharm Oncology Responds to Recent Stock Decline and Clarifies Exclusivity Rights for Clinical Ass...
GlobeNewswire 12/21/2018 Ziopharm Oncology to Present at the 37th Annual J.P. Morgan Healthcare Conference
GlobeNewswire 12/19/2018 Ziopharm Oncology and TriArm Therapeutics Establish Joint Venture to Develop and Commercialize Sleep...
GlobeNewswire 12/13/2018 Ziopharm Oncology Promotes Dr. David Mauney to President
GlobeNewswire 9/26/2018 Flow Traders Taps into Corvil’s Predictive Analytics to Simplify Intraday Risk Management
GlobeNewswire 9/25/2018 Ziopharm Oncology to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference
GlobeNewswire 9/14/2018 Global Gambling Market Outlook and Forecast 2018-2023: Key Players are Bet365, Galaxy Entertainment,...